Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Cash from Financing Activities came in at -$433.0 million in Q1 2026, down 67.83% year-on-year from -$1.3 billion in Q1 2025, and down 180.93% quarter-over-quarter from $535.0 million in Q4 2025.
Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$433.0 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$433.0 million, down 67.83% year-over-year; the trailing twelve-month figure through Mar 2026 was -$325.0 million (up 68.45% YoY), and the FY2025 annual result was -$150.0 million, up 82.92% from the prior year.
- Cash from Financing Activities came in at -$433.0 million for Q1 2026 at Iqvia Holdings, down from $535.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $535.0 million in Q4 2025 to a low of -$572.0 million in Q3 2025.
- The 5-year median for Cash from Financing Activities is -$144.0 million (2023), against an average of -$127.8 million.
- Across the five-year window, Cash from Financing Activities jumped 427.59% in 2023 and sank 373.68% in 2024, its largest moves.
- Iqvia Holdings' Cash from Financing Activities stood at -$193.0 million in 2022, then tumbled by 117.62% to -$420.0 million in 2023, then grew by 10.71% to -$375.0 million in 2024, then jumped by 242.67% to $535.0 million in 2025, then sank by 180.93% to -$433.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$433.0 million (Q1 2026), $535.0 million (Q4 2025), and -$572.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -433.00 Mn |
| Mar 31, 2026 | -433.00 Mn |
| Dec 31, 2025 | 535.00 Mn |
| Dec 31, 2025 | 535.00 Mn |
| Sep 30, 2025 | -572.00 Mn |
| Sep 30, 2025 | -572.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Mar 31, 2025 | -258.00 Mn |
| Mar 31, 2025 | -258.00 Mn |
| Dec 31, 2024 | -375.00 Mn |
| Dec 31, 2024 | -375.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Mar 31, 2024 | -106.00 Mn |
| Mar 31, 2024 | -106.00 Mn |
| Dec 31, 2023 | -420.00 Mn |
| Dec 31, 2023 | -420.00 Mn |